Brief: Biome Australia Says Ethics Approval Granted For Bmb18 Human Clinical Trial
02/02/2026 21:18
Feb 3 (Reuters) - Biome Australia BIO.AX: ETHICS APPROVAL GRANTED FOR BMB18 HUMAN CLINICAL TRIAL Further company coverage: BIO.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biome Australia
See all newsBrief: Biome Australia To Launch In China
Brief: Biome Australia Posts FY26 Sales Revenue Rises 30% To A$23.9 Million
Biome Australia hits two-month high on upbeat full-year sales revenue
Brief: Biome Australia Logs FY Revenue of AUD 23.9 Million
Biome Australia soars on signing Australian manufacturing deal